Researchers from Johns Hopkins Medicine have revealed that a cancer drug could be used to target a Parkinson’s disease (PD)-causing protein that drives the spread of alpha-synuclein, a key hallmark of the neurological condition.
US study suggests BMS’ cancer drug could ... - Cure Parkinson's
US study suggests BMS’ cancer drug could target Parkinson’s-causing protein
Written by
Farooqji
To view profiles and participate in discussions please or .
1 Reply
•
Discussed here: healthunlocked.com/cure-par...
Not what you're looking for?
You may also like...
Anle138b to target the toxic protein in Parkinson’s
In Parkinson’s, a protein called alpha-synuclein which is abundant in nerve cells, begins clumping...
Protein Discovered in Parkinson’s Disease Could Lead to New Treatments
https://news.cuanschutz.edu/news-stories/protein-discovered-in-parkinsons-disease-could-lead-to-new-
Could a prostate drug slow or stop Parkinson’s?
https://medium.com/parkinsons-uk/could-a-prostate-drug-slow-or-stop-parkinsons-86ee174f5f45
Compounds in Chinese Herbal Medicine May Treat Parkinson’s, Study Suggests
Chinese medicine, contains several active compounds that may be of therapeutic value in Parkinson’s...
Nano-plastics affect a specific protein found in the brain, causing changes linked to Parkinson’s disease and other types of dementia.
affect a specific protein found in the brain, causing changes linked to Parkinson’s disease and...